Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Orsolya Oláh‐Németh"'
Autor:
Zsuzsanna Ujfaludi, Fruzsina Fazekas, Krisztina Biró, Orsolya Oláh-Németh, Istvan Buzogany, Farkas Sükösd, Tamás Beöthe, Tibor Pankotai
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract The imperative need for sensitive and precise tools is underscored in cancer diagnostics, with biomarkers playing a pivotal role in facilitating early detection and tumor diagnosis. Despite their classical pathological classification, testic
Externí odkaz:
https://doaj.org/article/e86b17d6dad54aaabaed0532ec440d24
Autor:
Vasiliki Pantazi, Vanda Miklós, Paul Smith, Orsolya Oláh-Németh, Gabriella Pankotai-Bodó, Divya Teja Dondapati, Ferhan Ayaydin, Vincenzo D’Angiolella, Tibor Pankotai
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-19 (2024)
Abstract Breast cancer is a prevalent and significant cause of mortality in women, and manifests as six molecular subtypes. Its further histologic classification into non-invasive ductal or lobular carcinoma (DCIS) and invasive carcinoma (ILC or IDC)
Externí odkaz:
https://doaj.org/article/44bc09d4bb5f407a90ab675771e37f2b
Autor:
Anita Sejben, Fanni Hegedűs, Szintia Almási, Márton Berta, Orsolya Oláh‐Németh, Tamás Zombori
Publikováno v:
Thoracic Cancer, Vol 14, Iss 11, Pp 963-968 (2023)
Abstract Introduction The use of neoadjuvant therapy (NAT) has been showing an incraesing tendency in the treatment of locally advanced breast cancer. The evaluation of residual cancer could be performed by Residual Cancer Burden (RCB) calculator. Th
Externí odkaz:
https://doaj.org/article/901619d31c8f4d6c841921d706f6c6e1
Autor:
Barbara N. Borsos, Zoltán G. Páhi, Zsuzsanna Ujfaludi, Farkas Sükösd, Alíz Nikolényi, Sarolta Bankó, Gabriella Pankotai-Bodó, Orsolya Oláh-Németh, Tibor Pankotai
Publikováno v:
Cells, Vol 11, Iss 17, p 2721 (2022)
Breast cancer is the most frequent cancer with a high fatality rate amongst women worldwide. Diagnosing at an early stage is challenging, and due to the limitations of the currently used techniques, including mammography and imaging diagnostics, it s
Externí odkaz:
https://doaj.org/article/4236cbd16bd44deaa805040b79cfecf9
Autor:
Vörös, László Tabár, Renáta Bozó, Peter B. Dean, Katalin Ormándi, Olga Puchkova, Orsolya Oláh-Németh, István Balázs Németh, Zoltán Veréb, Ming-Fang Yen, Li-Sheng Chen, Hsiu-Hsi Chen, András
Publikováno v:
International Journal of Molecular Sciences; Volume 24; Issue 13; Pages: 10752
Classic diffusely infiltrating lobular carcinoma has imaging features divergent from the breast cancers originating from the terminal ductal lobular units and from the major lactiferous ducts. Although the term “invasive lobular carcinoma” implie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::c80875fb08e18eb0e30bed529de4b6db
Autor:
Bence Nagy-Mikó, Orsolya Németh-Szatmári, Réka Faragó-Mészáros, Aliz Csókási, Bence Bognár, Nóra Ördög, Barbara N. Borsos, Hajnalka Majoros, Zsuzsanna Ujfaludi, Orsolya Oláh-Németh, Aliz Nikolényi, Ágnes Dobi, Renáta Kószó, Dóra Sántha, György Lázár, Zsolt Simonka, Attila Paszt, Katalin Ormándi, Tibor Pankotai, Imre M. Boros, Zoltán Villányi, András Vörös
We aimed to investigate the contribution of co-translational protein aggregation to the chemotherapy resistance of tumor cells. Increased co-translational protein aggregation reflects altered translation regulation that may have the potential to buff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::58b565ea54e71304666d0a63b023cc12
https://doi.org/10.1101/2023.01.13.523908
https://doi.org/10.1101/2023.01.13.523908
Autor:
Bálint Cserni, Rita Bori, Erika Csörgő, Orsolya Oláh-Németh, Tamás Pancsa, Anita Sejben, István Sejben, András Vörös, Tamás Zombori, Tibor Nyári, Gábor Cserni
Publikováno v:
Pathology, research and practice. 229
Histological grade is one of the most important prognosticators of breast cancer which is available for nearly all cases. It also makes part of several multivariable analysis derived combined prognostic profiles despite concerns about its reproducibi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2be9be410b9ea793b77a29264ae984d8
https://pubmed.ncbi.nlm.nih.gov/34920295
https://pubmed.ncbi.nlm.nih.gov/34920295
Autor:
Gábor Cserni, Tamás Zombori, Erika Csörgő, Orsolya Oláh-Németh, Rita Bori, Anita Sejben, Tibor Nyári, Tamás Pancsa, Bálint Cserni, András Vörös, István Sejben
Publikováno v:
Virchows Archiv
The reproducibility of assessing potential biomarkers is crucial for their implementation. ONEST (Observers Needed to Evaluate Subjective Tests) has been recently introduced as a new additive evaluation method for the assessment of reliability, by de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::078917aab96272b4afcea534f2f1447f
https://pubmed.ncbi.nlm.nih.gov/34415429
https://pubmed.ncbi.nlm.nih.gov/34415429
Autor:
Márton Zsolt Enyedi, Orsolya Oláh-Németh, Bernadett Csányi, Farkas Sükösd, Alíz Nikolényi, Gyöngyi Kelemen, Zsuzsanna Kahán, László Tordai, Lajos Haracska, Sára Pólya, Ágnes Dobi, Éva Szilágyi, Dóra Sántha, Eszter Sági-Zsigmond, Erzsébet Valicsek, Katalin Priskin, Rozália Tóth, Gábor Jaksa, Lajos Pintér, Gabriella Uhercsák
Publikováno v:
Cancers
Volume 13
Issue 14
Cancers, Vol 13, Iss 3489, p 3489 (2021)
Volume 13
Issue 14
Cancers, Vol 13, Iss 3489, p 3489 (2021)
Circulating tumor DNA (ctDNA) is increasingly employed in the screening, follow-up, and monitoring of the continuously evolving tumor
however, most ctDNA assays validated for clinical use cannot maintain the right balance between sensitivity, co
however, most ctDNA assays validated for clinical use cannot maintain the right balance between sensitivity, co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99bf755f844fd87ace9b9119611d295b
https://doi.org/10.3390/cancers13143489
https://doi.org/10.3390/cancers13143489